Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. - Wikidata - awgldk - TriplyDB

Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.

Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.

http://www.wikidata.org/entity/Q33706349

about

Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm Cancer stem cells and exosome signaling Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples.Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma Liquid crystal droplet-based amplification of microvesicles that are shed by mammalian cells.Dynamic probabilistic threshold networks to infer signaling pathways from time-course perturbation data.Saline is a more appropriate solution for microvesicles for flow cytometric analyses.Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.Extracellular Vesicles as a Source of Urological Biomarkers: Lessons Learned From Advances and Challenges in Clinical Applications to Major Diseases.Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation.Predictive prognostic role of miR-181a with discrepancy in the liver and serum of genotype 4 hepatitis C virus patients Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.B-cell receptor signaling as a driver of lymphoma development and evolution.Relationship between circulating and tissue microRNAs in a murine model of breast cancer Axl as a mediator of cellular growth and survival Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours.The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.Microvesicles secreted from human multiple myeloma cells promote angiogenesis.Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control.Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors.Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring.CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p.Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival.Oncogenic extracellular vesicles in brain tumor progression Impact of collection, isolation and storage methodology of circulating microvesicles on flow cytometric analysis Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy.Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.Axl-dependent signalling: a clinical update.Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.Critical signal transduction pathways in CLL.Comparison of microRNA expression profiles in K562-cells-derived microvesicles and parental cells, and analysis of their roles in leukemia.

P2860

Q26768704-DD1834B7-3E3E-4595-9D23-65B7D0F5DC0C Q27013625-DCE1830A-9EA2-4F98-8EFB-ED238380D0A8 Q27023509-5D2B44BC-2DBE-4FA5-AD4E-9D43C51F997C Q27303212-8747A189-811F-4B68-8585-E3B20B2483BE Q28077635-48884E53-37BA-41E6-8571-9686474C934B Q30596483-372BFC23-5B7F-47C5-9D67-323DB45F3738 Q30837758-FD055904-989C-43E1-9B4C-92532A2EDCF8 Q33798474-C7D13668-D4A0-47F0-85FF-D243C19D79E8 Q33817641-19599812-0B7F-4FE4-BD74-7A6FECEFA17B Q33871862-7E864F19-96D3-45DD-82BD-742DDF6C0F6E Q34056568-A51F64B8-65D3-46AC-AE1F-BBC31FC9DB3F Q34221664-AB9B83BE-0641-4CA7-9812-3AAD631BC14D Q34265451-1176D86A-F495-428A-A3D1-4F4D8AF83017 Q34282342-A3152D73-20CC-41E1-BCF7-BFD0D0AA808E Q34398579-4C25101D-2515-4D10-B798-0D62C5487208 Q34505424-15324486-4757-47EA-B51F-B69F84908906 Q34619118-F985559B-2753-4F26-9CE1-C1880E81CC75 Q34625129-7CFAD37E-8F4D-4E7B-AA79-1B2D70B22485 Q34667753-F8DA2251-9FEB-4B93-AF09-52F1AD8A2508 Q35022490-7152A72D-9F59-4F08-869B-E315D8A1B5F7 Q35077269-C41BEE9F-B0D7-4696-9E5D-A968F8B5CBD8 Q35131885-93BC5696-1AA7-47F2-9F56-D5C798E18905 Q35136736-6EA2B846-ED96-48FD-80EE-F6280CF2F924 Q35525598-7E051382-362C-4D95-BE5D-4DF3394C486C Q35633008-B54342A8-2D21-42E5-B642-124CA07220E9 Q35634885-D5667DA5-9FA5-4C2E-BF7D-2EBAB98C0458 Q35775881-E7E9D6BF-4FD0-4999-B247-F299C3E2191C Q35802914-97987E58-38CB-484B-ABFC-1E01FDF470E0 Q35824101-A350711A-B5BF-45DF-952B-793786B80625 Q35949262-EA002EEF-798A-4FCC-A588-1EBE25AD74D6 Q36193774-39144EF5-8EDB-454B-BCDB-86FBA54818E7 Q36336087-DFDCB00C-7563-41C8-9735-5CC03309FA93 Q36390609-82BC62F4-6329-4304-AC7F-97F031E22000 Q36561705-86D7DE82-9116-4F43-8363-64D7242A83D2 Q36651022-1399E4D6-1F75-473B-B82E-6F94A331F81C Q36720080-6E171E6F-A704-4832-9122-8E5C8A5DD6F3 Q36862781-E43FFAF8-06D9-455D-B227-38AFA794D04C Q37188389-216A06AA-AB4C-4EDF-A299-54789239A43D Q37571068-BD94E259-5C5B-4C72-97E5-C17522A55148 Q37582348-BC26380A-6251-4FC9-8BFC-53EE11A4053C

P2860

Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.

http://www.wikidata.org/entity/Q33706349

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Circulating microvesicles in B ...... tions for disease progression.

@ast

Circulating microvesicles in B ...... tions for disease progression.

@en

type

label

Circulating microvesicles in B ...... tions for disease progression.

@ast

Circulating microvesicles in B ...... tions for disease progression.

@en

prefLabel

Circulating microvesicles in B ...... tions for disease progression.

@ast

Circulating microvesicles in B ...... tions for disease progression.

@en

P1433

Q33706349-2A995160-91BB-4150-A8DB-F2B82780504E

P1476

Q33706349-8F9CC84D-8EB0-4F9A-9FDC-B65587DB33B8

P2093

Q33706349-0D41AE44-97A1-4347-8A47-7E2992A0E289

Q33706349-306DA2FF-8072-4380-8533-C6AD3E9442E8

Q33706349-A1C7A382-5FE8-43D0-99A5-1C969616CA41

Q33706349-A537622E-CA0F-4C58-ACA0-680E5C0CB7D8

Q33706349-C99CE358-4556-4DA4-AC6F-26F58643AA93

Q33706349-D87E9D6B-19A4-424E-BB71-C96170A1FD44

P2860

Q33706349-02393B4F-7E79-48E4-8573-98C51E6DC566

Q33706349-06690AC9-B957-49F9-8EC7-E1F892852E0A

Q33706349-0CD5C540-3931-4F53-9BF4-4A2364387B0A

Q33706349-0F986A5B-D6D2-4E93-AD0C-DB2C8F416BF8

Q33706349-11FF2122-8F95-466A-9210-CCA7E60C715C

Q33706349-18F4BA7C-DA38-4ED6-94E0-116A11FCE044

Q33706349-19DE7704-A126-4C6E-A861-D06E1D7EFDC4

Q33706349-2648CF65-1F18-41F4-8840-ABDBBD71ED57

Q33706349-2C4409C1-4A57-4841-B89F-79134020CAC2

Q33706349-31524E56-7F13-4DB3-BFF6-5E596811F02A

P304

Q33706349-7364B525-F8A4-4590-A873-DAB17D925C8F

P31

Q33706349-CCFCAF64-C23F-4E19-8AB6-97C3CFDA1BB5

P356

Q33706349-56504675-5239-49BC-B096-FCC8238E14BB

P407

Q33706349-EA606C15-F252-4E3D-BFF9-3725F3E58835

P433

Q33706349-A1C01D54-8E44-4088-9FFE-D316BC28648B

P478

Q33706349-23350D32-EF63-4765-885B-41F09E0632E1

P577

Q33706349-F6D9329E-C26B-44D9-BEE1-23F6DEA0DAF3

P5875

Q33706349-7A7F5DDA-5805-4A3F-8B9F-94A43CF8A780

P698

Q33706349-EA6CBF76-A71D-4E59-9D65-38475A79F6C1

P921

Q33706349-2DB84CDF-ADBC-400C-9C94-0FFD6133C707

Q33706349-8BB7421A-1689-416D-A013-60740423705A

P932

Q33706349-A4D7D14A-AF98-4D8E-923E-A2B9D3890C8E

P356

BLOOD-2009-09-242719

P1433

P1476

Circulating microvesicles in B ...... tions for disease progression.

@en

P2093

Asish K Ghosh

http://www.w3.org/2001/XMLSchema#string

Charla R Secreto

http://www.w3.org/2001/XMLSchema#string

Debabrata Mukhopadhyay

http://www.w3.org/2001/XMLSchema#string

Neil E Kay

http://www.w3.org/2001/XMLSchema#string

Traci R Knox

http://www.w3.org/2001/XMLSchema#string

Wei Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Exosomal-like vesicles are present in human blood plasma

Vascular endothelial growth factor can signal through platelet-derived growth factor receptors

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition

TOR signaling in growth and metabolism

Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site

The TOR pathway: a target for cancer therapy

Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication

The renaissance of GSK3

Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis.

P304

1755-1764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-09-242719

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40696278

http://www.w3.org/2001/XMLSchema#string

P698

20018914

http://www.w3.org/2001/XMLSchema#string

P921

P932

2832808

http://www.w3.org/2001/XMLSchema#string